Quality Engineer: Diagnostics
San Francisco
Series A · $95M · 171d ago Posted 1y ago
Have your AI draft the answers and brief you on Collate→Why join Collate?
Life sciences teams still spend huge hours on regulated paperwork, and AI can only now draft and check it well. If Collate pulls it off, this San Francisco platform could become where every device, diagnostics and drug company drafts its paperwork, from concept to market. Y Combinator, First Round and Redpoint backed a $95M Series A, bigger than nearly nine in ten Series A rounds this half, on top of $125M raised in total.
JustBacked's take, based on Collate's own site and its funding and hiring data.
The full description is on the company's site.